Loading the map…

Ready-made interactive leisure and entertainment software development · London

Eyenapse

Eyenapse Ltd

Net liabilitiesActiveLatest figures: 2025Abridged accountsCompany only11 years on the register

Private limited company registered in London, classed under “Ready-made interactive leisure and entertainment software development”.

Headline figures

FY to Aug 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

What the numbers say

1 finding from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20212022202320242025
Profit after tax—
Turnover
Net assets
Cash
Employees

Every figure for all 5 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet2022202320242025
Fixed assets
Current assets
Net current assets
Creditors due after a year
Net assets
Ratios
Profit marginProfit after tax as a share of turnover

5 balance-sheet lines and 1 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Eyenapse do?

Private limited company registered in London, classed under “Ready-made interactive leisure and entertainment software development”.

›How much turnover does Eyenapse make?

Answered in the full report

›Is Eyenapse profitable?

Eyenapse's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Eyenapse?

Answered in the full report

›Where is Eyenapse based?

Its registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, in London.

›When was Eyenapse founded?

Eyenapse Ltd was incorporated on 4 August 2015.

›Is Eyenapse still trading?

The register lists Eyenapse Ltd as active.